ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
116 hedge funds and large institutions have $940M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 17 closing their positions.
153% more call options, than puts
Call options by funds: $6.85M | Put options by funds: $2.71M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
58% more capital invested
Capital invested by funds: $596M → $940M (+$344M)
53% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 17
18% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 33
8% more funds holding
Funds holding: 107 → 116 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$31.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.5M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$19.4M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.4M |
| 5 |
Bank of New York Mellon
New York
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$29.4M |
| 2 |
BC
Broadfin Capital
New York
|
-$13.5M |
| 3 |
QF
QVT Financial
New York
|
-$10.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$9.38M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$8.7M |
ANAC Hedge Fund Activity: Q3 2014 in Review
116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2014, worth a combined $940M — up 58% from $596M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ANAC positions and 17 closed out — a net gain of 9 holders — while 39 added to existing stakes and 33 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.6M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $29.4M sold.
- 116 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2014, up from 107 in Q2 2014.
- Funds reported $940M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2014, up 58% quarter-over-quarter.
- 26 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2014 and 17 closed out, a net change of +9 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2014 was Point72 Asset Management, an estimated $31.6M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2014 was Westfield Capital Management, an estimated $29.4M sold.
Based on aggregated 13F filings for Q3 2014.